md semaglutide Compounded – BloomMD EllieMD | Weight Loss -

By 2022, approximately 22.1% of semaglutide prescriptions were off-label, reflecting a significant increase driven by anecdotal reports and celebrity endorsements promoting its efficacy for cosmetic or non-medical weight reduction

A triple agonist (Retatrutide (GLP-1 + GIP + glucagon) is expected in a couple of years, plus oral versions that could help with dosing are expected to come online over the next couple of years as well

This isnt just about aesthetics the weight gained during menopause tends to settle as visceral fat around the abdomen, the metabolically dangerous kind linked to cardiovascular disease, type 2 diabetes, and metabolic syndrome

those with heart or kidney conditions should follow their clinician's specific guidance on fluid intake